期刊文献+

血清脂肪细胞脂肪酸结合蛋白与社区人群2型糖尿病的相关性研究 被引量:15

Relations between serum adipocyte fatty acid-binding protein and type 2 diabetes in a community population
下载PDF
导出
摘要 目的研究血清脂肪细胞脂肪酸结合蛋白(A-FABP)水平与社区人群2型糖尿病的相关性。方法在广州市海珠区整群分层随机抽样法抽取255名45~85岁社区居民,平均年龄63.90岁,测定空腹血糖(FPG)、餐后2小时血糖(2hPG)、糖化血红蛋白(HbA1c)、体重指数(BMI)、腰围(WC)、臀围(HC)、腰臀比(WHR)、血压(BP)、甘油三脂(TG)、胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C),计算胰岛素抵抗指数(HOMA-IR),酶联免疫吸附法(ELISA)测定血清A-FABP及空腹胰岛素(FINs)水平,根据血糖情况分为3组:血糖正常组(A组):90例,糖耐量受损组(B组):85例,糖尿病组(C组):80例,比较各组A-FABP的水平。结果与A组相比,B组、C组FPG、2hPGh、HbA1C、HOMA-IR、SBP、WC、WHR均明显升高(P=0.00),FINs、DBP、TG、HDL-C也显著增高(P=0.038、0.047、0.01、0.046);与B组相比,C组FPG、2hPG、HbA1c、TG、SBP均明显升高(P=0.00),FINs、BMI、WC、DBP、HDL-C也显著增高(P=0.012、0.006、0.03、0.019、0.029)。A-FABP在A组、B组和C组的浓度差异有统计学意义(P=0.00),呈升高趋势。而以上3组年龄差异对A-FABP的影响无统计学意义(P〉0.05)。A-FABP浓度与FPB、2hPG、FINS、WHR、BMI、WC、SBP、HOMA-IR呈直线正相关,与TG、HDL-C呈负相关(P=0.00)。结论血清A-FABP表达升高与糖调节异常相关,是社区人群2型糖尿病发生、发展的重要标志物。 Objective To study the relationship between the serum levels of adipocyte fatty acid-binding protein(A-FABP) level and type 2 diabetes mellitus in a community population.Methods A total of 255 residents(aged 45-85 years) were randomly selected from 4 communities in Guangzhou to examine the fasting plasma glucose(FPG),2-hour postprandial blood glucose(2hPG),glycosylated hemoglobin(HbA1c),body mass index(BMI),waist circumference(WC),hip circumference(HC),waist-to-hip ratio(WHR),blood pressure(BP),triglyceride(TG),cholesterol(TC),high-density lipoprotein cholesterol(HDL-C),and low-density lipoprotein cholesterol(LDL-C).The insulin resistance index(HOMA-IR) was calculated and enzyme-linked immunosorbent assay(ELISA) was used to determine serum A-FABP and fasting insulin(FINs) levels.The cases were divided into 3 groups according to blood glucose level,namely the normal group(group A,n=90),impaired glucose tolerance group(group B,n=85),and diabetic group(group C,n=80),and the A-FABP levels were compared between them.Results Compared with group A,the subjects in groups B and C showed significantly increased FPG,2hPGh,HbA1C,HOMA-IR,systolic blood pressure(SBP),and waist circumference(P=0.000) as well as FINs,WHR,diastolic blood pressure(DBP),TG,and HDL-C(P=0.038,0.047,0.01,and 0.046,respectively).Compared with group B,group C showed significantly higher FPG,2hPG,HbA1c,TG,and SBP(P=0.00),with also higher levels of FINs,BMI,WC,DBP,and HDL-C(P=0.012,0.006,0.03,0.019,and 0.029,respectively).A-FABP increased significantly in the order of group A,B,and C(P=0.00),and this result was not affected by the differences in age between the 3 groups(P0.05).A-FABP level was positively correlated to FPB,2hPG,FINS,WHR,BMI,WC,SBP,and HOMA-IR,but inversely to TG and HDL-C(P=0.00).Conclusion Elevated serum A-FABP is closely related to glucose metabolism disorder,and A-FABP may serve as a useful marker for the occurrence and development of type 2 diabetes in the community population.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2011年第3期508-511,共4页 Journal of Southern Medical University
基金 广东省科技计划项目(2007-Z-005)
关键词 脂肪细胞脂肪酸结合蛋白 社区人群 2型糖尿病 adipocyte fatty acid-binding protein community groups type 2 diabetes
  • 相关文献

参考文献13

  • 1Coe NR, Bemlohr DA. Physiological properties and functions of intracellulary acid-binding proteins [J]. Biochim Biophys Acta, 1998,1391(3): 287-306.
  • 2Zimmerman AW, Veerkamp JH. New insights into the structure and function of fatty acid-binding poteins [J]. Cell Mol Life Sci, 2002, 59(7): 1096-1116.
  • 3Gregoire FM. Adipocyte differentiation: from fibroblast to endocrine cell [J]. Exp Biol Med (Maywood), 2001, 226(11): 997-1002.
  • 4Hotamisligil GS, Johnson RS, Distel RJ, et al. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein [J]. Science, 1996, 274 (5291): 1377-9.
  • 5Sun L, Nicholson AC, Hajjar DP, et al. Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line [J]. Lipid Res, 2003, 44(10): 1877-86.
  • 6Tso AW, Xu A, Sham PC, et al. Serum adipocyte fatty acid binding protein as anew biomarker predicting the devdopment of type 2 diabetes-a 10-ar prospective study in Chinese [J]. Diabetes Care, 2007, 30(10): 2667-72.
  • 7Chen C, Tso AW, Law LS, et al. Plasma level of pigment epithelium-derived factor is independently associated with the development of the metabolic syndrome in Chinese men: a 10-year prospective study [J]. Clin Endocrinol Metab, 2010, 95(11): 5074-81.
  • 8Xu A, Wang Y, Xu JY, et al. Adipocyte fatty acid binding proteinis a plasma biomarker closely associated with obesity and metabolic syndrome[J]. ClinChem, 2006, 52(3): 405-13.
  • 9Yeung DC, Xu A, Cheung SC, et al. Epidermal fatty-acid-binding protein: a new circulating biomarker associated with cardio-metabolic risk factors and carotid atherosclerosis [J]. Eur Heart. 2008, 29(17): 2156-63.
  • 10Xu A, Tso AW, Cheung BM, et al. Circulating adipocyte-fatty acidbinding protein levels predict the development of the metabolic syndrome: a 5-year pro-spectivestudy [J]. Circulation, 2007(12), 115: 1537-43.

二级参考文献17

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3046
  • 2刘梅颜,胡大一,闫丽,刘文红,刘如辉.高水平纤维蛋白原与冠状动脉狭窄严重程度相关性探讨[J].中华内科杂志,2004,43(11):820-823. 被引量:37
  • 3Deckert T, Fedt, Rasmussen B, Borch, Johnsen K, et al. Albuminuria reflects widespread vascular damage. The Steno hypothesis[J].Diabetologia, 1989, 32:219-26.
  • 4Kahn SE, Zinman B, Haffiner SM, et al. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes [J].Diabetes, 2006, 55: 2357-64.
  • 5Ryan T J, Bauman WB, Kennedy JW, et al. Guidelines for percutaneous transluminal coronary angioplasty [J]. Circulation, 1993, 88(6): 2987-3007.
  • 6Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [J]. Am J Cardiol, 1983, 51 (3): 606.
  • 7Mann JF, Gerstein HC, Pogue J, et al. Renal insufficiency a predictor of cardiovascular outcomes and the impact of ramipril:the HOPE randomized trial [J ]. Ann Intern Med, 2001, 134(8): 629-36.
  • 8Gcluk CA, Tio RA, Tijsseu JG, et al. Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort: an observational study[J]. Neth Heart J, 2007, 15: 133-41.
  • 9Jassal SK, Langenberg C, von Mtihlen D, et al. Usefulness of microalbuminuria versus the metabolic syndrome as a predictor of cardiovascular disease in women and men>40 years of age (from the Rancho Bernardo Study)[J]. Am J Cardiol, 2008, 101(9): 1275-80.
  • 10Fichtlscherer S, Heeschen C, Zeiher AM. Inflammatory markers and coronary artery disease [J].Curr Opin Pharmacol, 2004, 4 (2): 124-31.

共引文献3

同被引文献112

引证文献15

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部